title: The BENEFIT Trial: Where Do We Go from Here?
authors.affiliation: Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland and Rio de Janeiro, Brazil.|The Global Chagas Disease Coalition, Barcelona, Spain.
authors.forename: Bernard
authors.initials: B
authors.lastname: Pecoul
authors.affiliation: Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland and Rio de Janeiro, Brazil.|The Global Chagas Disease Coalition, Barcelona, Spain.
authors.forename: Carolina
authors.initials: C
authors.lastname: Batista
authors.affiliation: Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland and Rio de Janeiro, Brazil.|The Global Chagas Disease Coalition, Barcelona, Spain.
authors.forename: Eric
authors.initials: E
authors.lastname: Stobbaerts
authors.affiliation: Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland and Rio de Janeiro, Brazil.|The Global Chagas Disease Coalition, Barcelona, Spain.
authors.forename: Isabella
authors.initials: I
authors.lastname: Ribeiro
authors.affiliation: The Global Chagas Disease Coalition, Barcelona, Spain.|IS Global and the Barcelona Centre for International Health Research (CRESIB), Barcelona, Spain.
authors.forename: Rafael
authors.initials: R
authors.lastname: Vilasanjuan
authors.affiliation: The Global Chagas Disease Coalition, Barcelona, Spain.|IS Global and the Barcelona Centre for International Health Research (CRESIB), Barcelona, Spain.
authors.forename: Joaquim
authors.initials: J
authors.lastname: Gascon
authors.affiliation: The Global Chagas Disease Coalition, Barcelona, Spain.|IS Global and the Barcelona Centre for International Health Research (CRESIB), Barcelona, Spain.
authors.forename: Maria Jesus
authors.initials: MJ
authors.lastname: Pinazo
authors.affiliation: The Global Chagas Disease Coalition, Barcelona, Spain.|IS Global and the Barcelona Centre for International Health Research (CRESIB), Barcelona, Spain.
authors.forename: Silvia
authors.initials: S
authors.lastname: Moriana
authors.affiliation: The Global Chagas Disease Coalition, Barcelona, Spain.|Fundacion Mundo Sano, Buenos Aires, Argentina, and Madrid, Spain.
authors.forename: Silvia
authors.initials: S
authors.lastname: Gold
authors.affiliation: The Global Chagas Disease Coalition, Barcelona, Spain.|Fundacion Mundo Sano, Buenos Aires, Argentina, and Madrid, Spain.
authors.forename: Ana
authors.initials: A
authors.lastname: Pereiro
authors.affiliation: The Global Chagas Disease Coalition, Barcelona, Spain.|Fundacion Mundo Sano, Buenos Aires, Argentina, and Madrid, Spain.
authors.forename: Miriam
authors.initials: M
authors.lastname: Navarro
authors.affiliation: The Global Chagas Disease Coalition, Barcelona, Spain.|Fundacion Ceades and Universidad Mayor de San Simon (UMSS), Cochabamba, Bolivia.
authors.forename: Faustino
authors.initials: F
authors.lastname: Torrico
authors.affiliation: The Global Chagas Disease Coalition, Barcelona, Spain.|Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, National School of Tropical Medicine at Baylor College of Medicine, Houston, Texas, United States of America.
authors.forename: Maria Elena
authors.initials: ME
authors.lastname: Bottazzi
authors.affiliation: The Global Chagas Disease Coalition, Barcelona, Spain.|Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, National School of Tropical Medicine at Baylor College of Medicine, Houston, Texas, United States of America.
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Hotez
mesh_terms: D000981:Antiprotozoal Agents / Q000008:administration & dosage*; D014355:Chagas Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000469:parasitology; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D009593:Nitroimidazoles / Q000008:administration & dosage*; D014349:Trypanosoma cruzi / Q000187:drug effects / Q000502:physiology; D014944:World Health Organization
chemical_list: D000981:Antiprotozoal Agents; D009593:Nitroimidazoles; C009999:benzonidazole